Skip to main content
Signal8

Nickerson Joan

SEC insider (Form 3/4/5 filer). CIK 0001964461. Chief Administrative Officer at Verve Therapeutics, Inc. (VERV). 11 reported Form 4/5 transactions since Sep 2024; latest on Jul 25, 2025. Located in BOSTON, MA.

Companies Nickerson Joan has filed insider reports for

  • Verve Therapeutics, Inc. (VERV): Officer, Chief Administrative Officer
Nickerson Joan profile photo

Nickerson Joan

CIK: 0001964461

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (9.1%)

Position reduction

Option Exercises (M)1 (9.1%)

Derivative conversions

Awards (A)2 (18.2%)

Compensation grants

Other (G, F, J, C, D, …)7 (63.6%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Verve Therapeutics, Inc. logo
VERV

Verve Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (11 total)

  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Tender Offer
    Direct
    17.4K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Restricted Stock Units

    Direct
    18K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Restricted Stock Units

    Direct
    6.6K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Stock Option (right to buy)

    Direct
    102K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Stock Option (right to buy)

    Direct
    125K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Stock Option (right to buy)

    Direct
    225K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jul 25, 2025
    Disposition

    Restricted Stock Units

    Direct
    40K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Apr 2, 2025
    Sale
    Direct
    2.8K shares at avg. $4.15$12K
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Apr 1, 2025
    Exercise
    Direct
    9.3K shares-
  • Verve Therapeutics, Inc. logo
    VERV

    Verve Therapeutics, Inc.

    Jan 8, 2025
    Award

    Stock Option (right to buy)

    Direct
    225K shares-

1-10 of 11